6
staff
Richard Moscicki
Richard (Rich) A. Moscicki, MD, is the executive vice president for science and regulatory advoca
cy and the chief medical officer at Pharmaceutical Research and Manufacturers of America (PhRMA).
+ Read More
article
Former SEC Commissioner Michael Piwowar To Lead Milken Institute Center For Financial Markets
WASHINGTON, September 5, 2018 – Michael Piwowar, Ph.D., the respected economist and longtime commiss
ioner of the U.S.
+ Read More
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
Milken Institute Announces Tech Hub Partners Program to Link Business Leaders and Investors to Regional Tech Innovation Opportunities
July 23, 2024 (Washington, DC)—The Milken Institute announced today the development of a Tech Hub Pa
rtners program to strengthen the network of 31 Regional Innovation and Technology Hubs (Tech Hubs) across the US to link business leader
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article